Milestone for bERLinPro: photocathodes with high quantum efficiency
Photocathode in superconducting photoinjector system. © J. Kühn/HZB
The superconducting photoinjector system (1): The photocathode (3) is excited by a green laser (2) and emits electrons (4) which are accelerated in the superconducting RF cavity. © Britta Mießen
Photocathode after its production in the preparatory system. © J. Kühn/HZB
A team at the HZB has improved the manufacturing process of photocathodes and can now provide photocathodes with high quantum efficiency for bERLinPro.
Teams from the accelerator physics and the SRF groups at HZB are developing a superconducting linear accelerator featuring energy recovery (Energy Recovery Linac) as part of the bERLinPro project. It accelerates an intense electron beam that can then be used for various applications – such as generating brilliant synchrotron radiation. After use, the electron bunches are directed back to the superconducting linear accelerator, where they release almost all their remaining energy. This energy is then available for accelerating new electron bunches.
Electron source: photocathode
A crucial component of the design is the electron source. Electrons are generated by illuminating a photocathode with a green laser beam. The quantum efficiency, as it is referred to, indicates how many electrons the photocathode material emits when illuminated at a certain laser wavelength and power. Bialkali antimonides exhibit particularly high quantum efficiency in the region of visible light. However, thin films of these materials are highly reactive and therefore very sensitive, so they only work at ultra-high vacuum.
Manufacturing process modified
A HZB team headed by Martin Schmeißer, Dr. Julius Kühn, Dr. Sonal Mistry, and Prof. Thorsten Kamps has now greatly improved the performance of the photocathode so it is ready for use with bERLinPro. They modified the manufacturing process for the photocathodes of cesium- potassium-antimonide on a molybdenum substrate. The new process delivers the desired high quantum efficiency and stability. Studies showed that the photocathodes do not degrade, even at low temperatures. This is a critical prerequisite for operation within a superconducting electron source, where the cathode must be operated at temperatures far below zero.
High quantum efficiency
The physicists were able to demonstrate this performance with detailed studies: Even after its transport via the photocathode transfer system and introduction into the photo injector of the SRF, the quantum efficiency of the photocathode was still about five times higher than necessary to achieve the maximum electron-beam current needed for bERLinPro.
Milestone for bERLinPro
“An important milestone for bERLinPro has been reached. We now have the photocathodes available to generate the first electron beam from our SRF photoinjector at bERLinPro in 2019“, says Prof. Andreas Jankowiak, head of the HZB Institute for Accelerator Physics.
Published in Physical Review Accelerators and Beams (2018): "Addressing challenges related to the operation of Cs-K-Sb photocathodes in SRF photoinjectors"; M. A. H. Schmeisser, S. Mistry, H. Kirschner, S. Schubert, A. Jankowiak, T. Kamps, J. Kühn.
doi:10.1103/PhysRevAccelBeams.21.113401
- Catalysis research at HZB gets new facilityAs part of the CatLab project, HZB has acquired a unique facility for measuring the catalytic performance of thin-film catalysts. Built by ILS in Adlershof, it has now been delivered. The facility consists of a total of eight chemical reactors in which catalytic systems can be tested. At over €2.5 million, this is the largest single investment in the CatLab project.
- Protein crystallography at BESSY II: faster, better and more and more automaticMany diseases are linked to malfunctions of proteins in the organism. The three-dimensional architecture of these molecules is often highly complex, but it can provide valuable insights into biological processes and the development of drugs. X-ray diffraction at the MX beamlines of BESSY II can be used to decipher the 3D structure of proteins. To date, more than 5000 structures have been solved at the three MX beamlines. Here, we present a review and an outlook with Manfred Weiss, head of the research group for macromolecular crystallography.
- 5000th protein structure at BESSY II: Starting point for a COVID drugMany proteins have a complex architecture that enables biological functions. Molecules can bind to specific sites on a protein and alter its function. A team at HZB has now investigated the Nsp1 protein, which plays a role in infection with the SARS-CoV-2 virus. They analysed protein crystals, previously mixed with molecules from a fragment library, and discovered a total of 21 candidates as starting points for drug development. At the same time, they also decoded the 5000th structure at BESSY II.